Dialysis Market Tracks 5.03% Growth Through 2033 as HHS Kidney Care Plan Moves to Open the US Market: Cognitive Market Research and Consulting
HHS launched the Kidney Care National Plan on October 20, 2026
A federal plan to loosen the grip of two incumbents on the United States dialysis market has put a decades-old treatment category back in play for new entrants, device makers and home-care providers. According to analysis released today by Cognitive Market Research and Consulting, the global dialysis market is forecast to grow at a 5.03% compound annual growth rate from 2025 through 2033, a steady, demographically driven base that United States policy is now reshaping at the structural level rather than the demand level.
On October 20, the U.S. Department of Health and Human Services launched the Kidney Care National Plan, built around three priorities: preventing kidney failure, improving dialysis care while widening patient choice, and reforming the transplant system. The plan builds on the 2019 Advancing American Kidney Health executive order and advances a National Transplant Expansion Strategy. HHS has tied the agenda explicitly to competition, arguing that limited innovation in kidney care is a structural consequence of consolidation and administrative barriers to market entry. Axios, which received the plan first, reported that the two largest dialysis chains together hold roughly 74% of the United States market.
Chronic kidney disease affects approximately 37 million American adults, or more than one in ten, according to CDC data cited by HHS.
Key Market Drivers & Industry Shifts
The dialysis market has historically grown on patient volume: rising prevalence of diabetes and hypertension, an ageing population and expanding end-stage renal disease caseloads. The Kidney Care National Plan does not change that demand curve. It changes who is permitted to serve it, and where treatment is delivered.
Three shifts follow directly from the plan's stated priorities. Lower barriers to entry alter the competitive structure of United States dialysis services, which has been among the most concentrated care delivery categories in healthcare. A stated push on home and self-care options moves revenue from the dialysis centre end-use segment toward the home dialysis segment, which carries a different equipment, consumables and support economics profile. And an earlier-detection, prevention-first posture lengthens the pre-dialysis phase of the patient pathway, expanding demand for renal diagnostics and chronic kidney disease management ahead of the dialysis sale itself.
Equipment manufacturers and consumables suppliers are positioned differently from service operators under this plan. Where service revenue is exposed to incumbent market share being contested, device and consumables demand is tied to procedure volume and modality mix and a shift toward home-based treatment is additive to peritoneal dialysis systems, portable equipment and home-suitable consumables.
Industry Insights
"The United States dialysis market has been concentrated enough that competitive position was effectively settled. A federal plan aimed squarely at entry barriers reopens that question for every supplier in the category," said Supriya - Healthcare market research analyst, Cognitive Market Research and Consulting. "The forecast growth rate is not what changes here. What changes is modality mix and who captures it — and the suppliers positioned for home-based treatment and earlier-stage renal management are holding the more defensible position through 2033."
"Our guidance to clients in this category is to stop reading the United States as a single mature market and start reading it as two: a contested service layer and an expanding home-care equipment layer with different buyers, different procurement cycles and different margin structures.
Key Findings Highlighted in the Report
- Growth rate: The global dialysis market is forecast to expand at 5.03% CAGR from 2025 to 2033, on a 2025 base year with 2022–2025 historical data and forecasts running to 2034.
- Modality split under review: The report segments the market by procedure type across hemodialysis and peritoneal dialysis, and by end use across home dialysis and dialysis centre - the exact boundary the HHS plan is designed to move.
- Where the hardware demand sits: Equipment is tracked across dialysis machines, water treatment systems and other equipment; consumables across dialyzers, catheters, access products, concentrates and other consumables.
- North American concentration: North America has been the dominant regional market, driven by high CKD and ESRD prevalence and high treatment rates in the United States and Canada - the same concentration the federal plan now identifies as a structural problem.
- Supplier set: The competitive landscape covers Baxter International, B. Braun Medical, DaVita, NIPRO Corporation, Asahi Kasei Medical, Diaverum AB, Kimal, BD and Nikkiso, with regional and country-level breakdowns available for each.
- Adjacent demand: Prevention and earlier detection priorities extend demand into renal biomarkers, kidney function testing and artificial kidney development - each tracked in separate Cognitive Market Research and Consulting reports.
Methodology & Research Background
The analysis is drawn from the 8th Edition 2026 Dialysis Market Analysis, produced under Cognitive Market Research and Consulting's Full Truth methodology, a 70:30 primary-to-secondary research ratio supported by 54 expert interviews, coverage across 39+ countries and 10,400+ validated data points, with every data point reviewed by a minimum of two independent domain experts.
Policy detail in this release is sourced from the Department of Health and Human Services' October 20, 2026 announcement of the Kidney Care National Plan and contemporaneous reporting on it.
To view the complete dataset, market segmentation, regional and country-level forecasts and underlying methodology, access the full report:
https://www.cognitivemarketresearch.com/dialysis-market-report
Related coverage: https://www.cognitivemarketresearch.com/kidney-dialysis-equipment-market-report , https://www.cognitivemarketresearch.com/artificial-kidney-market-report , https://www.cognitivemarketresearch.com/renal-biomarkers-market-report
About Cognitive Market Research and Consulting
Cognitive Market Research and Consulting is a premier global market intelligence and consulting firm offering data-driven market surveys, competitive intelligence and predictive industry forecasting across more than 30 major global sectors. The firm is an ESOMAR and MRSI member and holds ISO 20252, ISO 9001, ISO 27001 and ISO 27701 certification.
Media contact info@cognitivemarketresearch.com | sales@cognitivemarketresearch.com USA: (+1) 929-659-6832 | India: (+91) 983-496-8611 G4060, Solitaire Business Hub, Viman Nagar, Pune, Maharashtra 411014 200 W Washington Ave, Sunnyvale, CA 94086
